http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20121180-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
filingDate 2010-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d81ec83e0f507757c6699ccbd07e9bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6cb7e73753d29287f67de89ccd1be59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4686820a41f6209c7a46f09ee177b715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac754b4a42596fbfde42687eafcb8a81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04e8a377e7893e97a669adee4ea46eb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_383cf0609f4c274b2539e1fbd1764e50
publicationDate 2012-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20121180-A1
titleOfInvention (HETEROARYLMETIL) THIOHIDANTOINS SUBSTITUTED AS ANTI-CANCER DRUGS
abstract REFERRING TO A COMPOUND OF FORMULA I, WHERE X IS N, CH; R1 IS C1-C3 ALKYL FLUORATED, OPTIONALLY FLUORATED C1-C4 ALCOXY, METOXY- (C2-C4 ALCOXY) PYRROLYL, AMONG OTHERS; R2 IS H, METHYL, AMINO, FLUORINE. THE PREFERRED COMPOUNDS ARE: 4- (3 - {[6- (1H-IMIDAZOL-1-IL) PYRIDIN-3-IL] METHYL} -4,4-DIMETHYL-5-OXO-2-THIOXOIMIDAZOLIDIN-1-IL) - 2- (TRIFLUOROMETHYL) BENZONITRILE; 4- (4,4-DIMETHYL-3 - {[2-METHYL-6- (TRIFLUORomethyl) PYRIDIN-3-IL] METHYL} -5-OXO-2-THIOXOIMIDAZOLIDIN-1-IL) -2- (TRIFLUORomethyl) BENZONITRILE ; 4- (4,4-DIMETHYL-5-OXO-3 - {[6- (2-OXOIMIDAZOLIDIN-1-IL) PYRIDIN-3-IL] METHYL} -2-THIOXOIMIDAZOLIDIN-1-IL) -2- (TRIFLUOROMETIL ) BENZONITRILE; AMONG OTHERS. SUCH COMPOUNDS ARE USEFUL IN THE TREATMENT OF CANCER
priorityDate 2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6373

Total number of triples: 39.